HI
Humankind Investments Portfolio holdings
AUM
$410M
This Quarter Return
+2.22%
1 Year Return
+11.36%
3 Year Return
+48.94%
5 Year Return
–
10 Year Return
–
AUM
$377M
AUM Growth
+$377M
(-0.32%)
Cap. Flow
-$8.86M
Cap. Flow
% of AUM
-2.35%
Top 10 Holdings %
Top 10 Hldgs %
64.66%
Holding
168
New
29
Increased
45
Reduced
51
Closed
28
Top Buys
| 1 |
Intel
INTC
|
$2.1M |
| 2 |
Colgate-Palmolive
CL
|
$1.46M |
| 3 |
Abbott
ABT
|
$1.09M |
| 4 |
Cigna
CI
|
$906K |
| 5 |
J.M. Smucker
SJM
|
$671K |
Top Sells
| 1 |
Vanguard Real Estate ETF
VNQ
|
$3.37M |
| 2 |
Microsoft
MSFT
|
$2.43M |
| 3 |
Apple
AAPL
|
$1.94M |
| 4 |
Ecolab
ECL
|
$1.56M |
| 5 |
Archer Daniels Midland
ADM
|
$1.54M |
Sector Composition
| 1 | Technology | 12.14% |
| 2 | Healthcare | 12% |
| 3 | Consumer Staples | 4.93% |
| 4 | Communication Services | 2.82% |
| 5 | Materials | 2.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Archer Daniels Midland
ADM
$29.8B
| $2.2M | 0.58% |
36,326
-25,499
| -41% | -$1.54M |
|
27
Pfizer
PFE
$142B
| $2.18M | 0.58% |
77,944
-22,153
| -22% | -$620K |
|
|
28
Intel
INTC
$106B
| $2.1M | 0.56% |
+67,783
| New | +$2.1M |
|
|
29
Colgate-Palmolive
CL
$68.2B
| $1.97M | 0.52% |
20,263
+15,065
| +290% | +$1.46M |
|
30
Corteva
CTVA
$50.3B
| $1.84M | 0.49% |
34,183
-11,671
| -25% | -$630K |
|
31
Becton Dickinson
BDX
$54B
| $1.62M | 0.43% |
6,930
+2,335
| +51% | +$546K |
|
32
Stryker
SYK
$149B
| $1.56M | 0.41% |
4,587
+1,327
| +41% | +$452K |
|
|
33
Abbott
ABT
$229B
| $1.52M | 0.4% |
14,621
+10,466
| +252% | +$1.09M |
|
34
Amgen
AMGN
$154B
| $1.51M | 0.4% |
4,847
+783
| +19% | +$245K |
|
35
Walmart
WMT
$780B
| $1.51M | 0.4% |
22,266
-5,883
| -21% | -$398K |
|
|
36
Cigna
CI
$80.3B
| $1.5M | 0.4% |
4,534
+2,741
| +153% | +$906K |
|
37
Bunge Global
BG
$16.3B
| $1.35M | 0.36% |
12,655
-11,205
| -47% | -$1.2M |
|
38
UnitedHealth
UNH
$280B
| $1.32M | 0.35% |
2,598
-520
| -17% | -$265K |
|
39
HCA Healthcare
HCA
$94.9B
| $1.32M | 0.35% |
4,113
-149
| -3% | -$47.9K |
|
40
CF Industries
CF
$14.2B
| $1.31M | 0.35% |
17,666
+2,381
| +16% | +$176K |
|
41
GE HealthCare
GEHC
$32.7B
| $1.27M | 0.34% |
16,350
+4,309
| +36% | +$336K |
|
|
42
Ecolab
ECL
$78B
| $1.27M | 0.34% |
5,342
-6,559
| -55% | -$1.56M |
|
43
HP
HPQ
$27B
| $1.26M | 0.33% |
36,022
+11,187
| +45% | +$392K |
|
44
Verizon
VZ
$185B
| $1.26M | 0.33% |
30,574
-15,624
| -34% | -$644K |
|
45
Labcorp
LH
$22.8B
| $1.26M | 0.33% |
6,175
+2,845
| +85% | +$579K |
|
46
Dell
DELL
$81.9B
| $1.24M | 0.33% |
9,016
+4,378
| +94% | +$604K |
|
47
AT&T
T
$208B
| $1.23M | 0.33% |
64,567
+18,896
| +41% | +$361K |
|
48
Bristol-Myers Squibb
BMY
$96.5B
| $1.21M | 0.32% |
29,170
+1,431
| +5% | +$59.4K |
|
49
Thermo Fisher Scientific
TMO
$184B
| $1.14M | 0.3% |
2,066
+392
| +23% | +$217K |
|
50
Baxter International
BAX
$12.4B
| $1.09M | 0.29% |
32,726
+20,013
| +157% | +$669K |
|